Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients.
Salam A, Ali A, Nishan U, Khan N, Ibrahim MA, Iqbal Z, Muhammad N, Fayyaz A, Muhammad F, Mateen A, Wu Z, Afridi S.
Salam A, et al. Among authors: mateen a.
ACS Pharmacol Transl Sci. 2024 Oct 7;7(11):3585-3591. doi: 10.1021/acsptsci.4c00490. eCollection 2024 Nov 8.
ACS Pharmacol Transl Sci. 2024.
PMID: 39539267